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METABOLISM OF CYCLOHEXYL- 
ISOPROPYLAMINES IN MAN 
IN COMPARISON WITH AMPHETAMINES*)
T , B. VREE, J. TH. M. VAN DER LOGT, P. TH. HENDERSON 
and J. M. VAN ROSSUM
Department of Pharmacology, University of Nijmegen
I n tr o d u c tio n
The metabolism of amphetamines and their derivatives with substituents in the propyl 
side chain have been studied extensively over the past 10 years. (1, 3,4, 6, 7,8, 9,10,14, 
15, 20). The possible routes for metabolism are parahydroxylation, a-C-oxidation 
(deamination and dealkylation) and N-oxidation. The lipid-solubility plays an important 
role in directing routes of the total elimination, because a high lipid-solubility results in 
a less renal clearance, a great volume of distribution, a longer life time in the body and 
consequently more extensive metabolism. Weak lipophihc properties cause a high renal 
excretion of the unchanged compound and subsequently low degree of metabolism, such 
as can be observed with the ephedrines (15, 20).
In general, ring substitution results in an increase of lipid-solubüity, accompanied by 
a greater metabolic clearance. This has been observed for fenfluramine (4), chloro- 
amphetamine (7) and methoxyphenamine (19). Relatively little is known about hydrogen 
substituted amphetamine, the cyclohexylisoprojpylamine, and its N-alkyl substituted 
derivatives, (‘saturated amphetamines’), while N-methylcyclohexylisopropylamine, 
propylhexedrine, is in use as an anti-obesity drug.
The aim of the investigation was to study the influence of the hydrogen substitution 
on the metabolic pattem. The metabolic fate of the saturated amphetamines in man was 
compared with the known metabolic pathways of amphetamines and ephedrines.
E xperim en ta l
Synthesis: Amphetamine and derivatives (+ ), (—) were hydrogenated in gladal acetic 
add with PtOa/Ife (3 atm) in a Parr apparatus. The S (+ ) amphetamine was converted 
into S (—) cyclohexylisopropylamine. Ephedrines were treated in the same way to corre- 
sponding cyclohexylisopropanolamines. N-cycloalkylamphetamines were prepared by 
boiling (+ )  amphetamine in excess of cyclopentanon, cyclohexanon and cycloheptanon,
*) This work was supported in part by grants from the Netherlands Organisation for the 
Advancement of Pure Research (Z.W.O.) and from the Prevention Fund, Ministry of Health.
595
T. B. VREE ET AL.
resp. with Mg2S04, followed by reduction with sodiumborohydride. AU reactions were 
followed by means of combined GC-MS (LKB 9000).
Gas chromatography: H P402 gas chromatograph with flame ionisation detector. 
Colunms: 20% Apiezon M, 5% KOH ón Gaschrom Q 60—80 mesh and 3% OV 17 
on gaschrom Q 60—80-mesh. Amphetamines, ephedrines and its saturated analogues 
cannot be separated at these columns from each other. The hydroxy metabolites have 
a retention time of 2.20 times the retention time of the parent compound. After hydro- 
lysis of the urine with 6 n  HC1, no conjugated amphetamines could be detected.
Mass spectrometry: L.K.B. 9000 combined gas chromatograph- mass spectrometer, 
equipped with a column of 20% Apiezon-5% KOH on gaschrom Q 60—80 m. Column 
temperature 160°, separator 200°, ion source 290°, trapcurrent 60 [aA, accelerating voltage 
3,5 kV, ionisation voltage 20—70 eV. The hydroxy metabolites of the N-cyclohexyl- 
amphetamine could be separated at the column and the position of the OH group could 
be identified. With cyclohexylisopropylamines, the separation of the hydroxy metabolites 
was too poor. Full details will be described elsewhere (19).
Metabolism: 30—60 mg of the HC1 salts of the compounds were taken orally by healthy 
human subjects (25—30 years, 70—85 kg). The urine was kept acidic (pH 5 ±0.3) by the 
daily intake 4 x 2  grams of ammonium chloride (4 tablets of 0.5 g 4 dd). Each urine 
sample was collected, made alkaline, extracted with ether and analysed with the GLC 
as described before (14, 15). Renal excretion rate and cumulative renal excretion was 
plotted for each urine sample versus the time after administration (see Fig. 1—3) Dis- 
sociation constants (Ks) characterizing binding to microsomal enzymes were measured 
as described by Vree and Henderson (17,18).
Results and discussion
A. Excretion of the unchanged compound
After ingestion of cyclohexylisopropylamine or an N-alkyl substituted derivative by 
man, a very small amount of the parent compound was excreted unchanged in the urine.
T a ble  1
Excretion of unchanged amphetamines and cyclohexylisopropylamines in the urine of man
Compound
% dose excreted unchanged and half life time 
of elimination
S configuration Tl/2 R configuration Tl/2
Cyclohexylisopropylamine 7% 3 hr 6% 3 hr
. .  N-ïnethyl 7 3 7 5
. .  N-ethyl 4 3.5 4 3
. .  N-isopropyl 1 0.5 3 1
Amphetamine 70 7 90 8
. .  N-methyl 65 7 80 7
. .  N-ethyl 40 5 90 7
. .  N-isopropyl 10 3 85 ' 7
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Ia Table 1 the amounts excreted are given as well as the percentages obtained with the 
corresponding amphetamines (Fig. 1).
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Fig. 1. Renal excretion, urinary pH, average urine production, cumulative renal excretion of 
N-methylcyclohexylisopropylamine (propylhexedrine) and its metabolites cyclohexylisopropyl- 
amine and cyclohexanolisopropylamine. The metabolic processes are very fast, the renal excretion 
of the metabolites reached a maximum after 2—3 hours.
From the table it can be derived that as the saturated amphetamines are concemed 
there is no striking difference in metabolic behaviour between the various derivatives 
and between the different stereochemical configurations of those derivatives. All com- 
pounds are very well metabolized and the renal excretion of the unchanged compound
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is of minor importance .This is in contrast to the amphetamine series, where substantial 
amounts of unchanged compounds are excreted. For the derivatives with the S con- 
figuration the proportional excretion of the unchanged compound decreases with 
increasing alkyl substituent. However, this excretion is constant for the R configuration 
(14).
T ablf. 2
Percent dose excreted as ring hydroxylated metabolites into the urine of man
Compound
Configuration
( - ) S (+ )  R S/R
Cyclohexylisopropylamine 0 0
. .  N-methyl 6.0 10 0.60
. .  N-ethyl 37 55 0.67
. . N-isopropyl 55 85 0.64
The detection system used, makes it possible to detect the parahydroxylated meta­
bolites of the saturated amphetamine in contrast to parahydroxyamphetamine. In spite 
of this possibility, no trace of hydroxylated metabolite of cyclohexylisopropylamine was 
found. It must be concluded that the deamination is an extremely fast metabolic route 
in the metabolism of this parent compound. Most likely deamination and ring hydroxyl- 
ation are competitive pathways for elimination. With the amphetamines a-C-oxidation 
and renal excretion are the two metabolic routes.
B. Hydroxy metabolites
In comparison with the amphetamine metabolism, the most striking observation in the 
metabolism of saturated amphetamines is the hydroxylation of the cyclohexyl ring. The 
hydroxylation is prevailing when the seize of the substituent increases, concomitantly 
with increase of the lipid-solubüity. The degree of hydroxylation also depends upon the 
stereochemical configuration, but the ratio of hydroxylation of the R and S configuration 
is constant (Fig. 2). The results are summarized in Table 2.
T able  3
Aromatic hydroxylation of amphetamine antipodes in various species 
(after Sm it h  and D r in g ,  12)
% dose excreted as £-hydroxyamphetamine 
S . ( + )  R  (— ) R , S ( + ,  — )
Man 1.1 3.9 2.8
Guinea pig 0 1
Mouse 14 17
Rat 48 63 60
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The differences in percentage of the hydroxy metabolites in the R and S configuration 
might be explained with the aid of the competitive metabolic pathways, on the under- 
standing that the S-compound is more susceptible to a-C-oxidation than the R-form.
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Fig. 2. Difference in renal excretion rate between the R  (+ )  and S (—) configuration of the meta- 
bolite N-isopropyl-cyclohexanolisopropylamine. The R (+ )  configuration (T1/* =  4hr)ism uch  
slower metabolized (a-C-oxidation) than the S (—) configuration. The equal maximum renal 
excretion rate of both metabolites indicates that the rate of hydroxylation is independent of the 
stereochemical configuration of the side chain.
Deamination is so fast that N-dealkylated metabolites are hardly excreted unchanged 
in the urine (1—5%). As reported earlier, for amphetamines both reactions were extremely 
dependent upon the R- and S configuration (14). The same behaviour can be found with 
saturated amphetamines, the effect in some way is masked by the hydroxylation. D rin g  
(7) showed for some species the amounts of parahydroxylation of S- and R amphetamine, 
and he found the same differences in hydroxylated products, due to the difference in 
deamination of the amphetamine (Table 3).
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C. The hydroxylating etizyme system
Considering the metabolism of cyclohexylisopropylamines and amphetamines the 
question arises whether one enzyme performs both a-C-oxidation and ring hydroxylation, 
or different enzymes, or different active sites of one enzyme system are responsible for the 
conversion. What is the reason why with increasing size of the N-alkyl substituent with 
saturated amphetamines the ring hydroxylation increases while with amphetamines the 
a-C-oxidation increases. An explanation may be that with increasing the seize of t' 
substituent, the lipid-solubility increases too and that ca certain part’ of the enzyme can 
be reached while with amphetamines the nature of the C—H bond and therefore the rate 
of the a-C-oxidation is altered. This may be acceptable when one assumes that for all 
derivatives the rate of aromatic hydroxylation is low. The lipid-solubilities were measured, 
but it turned out that the corresponding derivatives of saturated and non saturated 
amphetamines have a fixed ratio of their partition coëfficiënt (Table 4),
T a ble  4
pKa values and partition coefficients of amphetamine, cyclohexylisopropylamine and derivatives
Compound pKa TPChept T PC  chlor APChept APCchlor
Amphetamine 9.90 1.88 146 0.005 0.48
. . N-methyl 10.10 5.14 565 0.015 1.10
. . N-ethyl 10.23 38.6 1790 0.060 2.67
, . N-isopropyl 10.14 117 4460 0.21 8.09
Cyclohexylisopropylamine 10.50 19.0 770 0.015 0.61
. . N-methyl 10.60 92.0 1860 0.058 1.17
. . N-ethyl 10.80 550 8350 0.22 3.34
. . N-isopropyl 10.60 1180 12900 0.74 8.10
TPC -  true partion coëfficiënt
APC -  apparent partition coëfficiënt
hept -  system heptane-water (Teorell buffer, pH 7.4)
chlor -  system chloroform-water (Teorell buffer, pH  7.4)
The different saturated amphetamines are about three times more lipid-soluble than 
the corresponding amphetamines. This difference in solubility does not explain the dif­
ferent enzymatic attack at the molecule. The difference between the two ring systems is 
the nature of the C-H bond that is attacked, aliphatic and aromatic, and the ‘shape’ 
of the molecule.
The phenyl ring is stabilized by its resonance energy of 36 kcal/mol. If one enzyme 
is postulated for hydroxylation of both phenyl ring and cyclohexyl ring than the resonance 
energy may act as a threshold. Due to its high activation energy of the hydroxylation 
of the phenyl the a-C-oxidation get a chance to occur as an alternative metabolic pathway. 
The cyclohexyl ring behaves like an aliphatic chain, in which the most outstanding C-H 
bond with the lowest energy is hydroxylated. It may be that different enzyme systems 
(mechanisms) are metabolizing these amphetamines. The compound ferrocenylisopropyl- 
amine exerts to be an excellent inhibitor of the metabolism of amphetamines in the rat 
(17,18). Ferrocenylisopropylamine binds very strongly to the cytochrome P-450 (Table 5)
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and in this way inhibits the a-C-oxidation. But, even when the ferrocenylisopropylamine 
was added in an excess of 50 times the concentration of saturated isopropylamphetamine 
in rats, the compound failed to inhibit the metabolism of saturated isopropylamphet­
amine. From this observation it must be concluded that the hydroxylation of the cyclo­
hexyl ring is mediated by an other mechanism than a-C-oxidation. The binding affinities 
of the amphetamines and its saturated analogues are found to be of the same magnitude 
rats. This means that the difference in structure of the phenyl and cyclohexyl ring has 
±iO influence at the interaction drug-cytochrome P-450. In Table 5 the binding affinities 
of the amphetamines and related compounds are given.
T able  5
Binding affinities of amphetamines, cyclohexylisopropylamines and related compounds to hepatic
cytochrome P-450 of the rat
Compound Ks value molar Type
Amphetamine (S) 5.0 X h-* o 1 03 I
Amphetamine (R) 4.5 X ÏO-3 I
N-isopropylamphetamine (S) 5.0 X 10-3 I
N-isopropylamphetamine (R) 4.1 X 10-3 I
Cyclohexylisopropylamine (S) 4.0 X io - 3 I
. .  N-isopropyl (S) 5.0 X 10-3 I
Benzphetamine (S) 5.5 X io -4 I
Ferrocenylisopropylamine 1.4 X 10-8 II
. . N-isopropyl 5.0 X ÏO-6 II
DPEA 1.4 X 10-8 'I
Imipramine 2.2 X 10-7 1(2)
Desmethylimipramine 2.7 X 10-6 1(2)
Amitriptyline 2.5 X 10-7 1(2)
L ew ander  (11) reported the inhibition of both parahydroxylation (95%) and de- 
amination (50%) of amphetamine by desmethylimipramine. The Ks value of imipramine 
and desmethylimipramine is of the same magnitude as that of ferrocenylisopropylamine 
(2) Table 5). This finding supports the idea that if the enzyme is blocked by these strong 
bounded compounds, all possible metabolic pathways that can be performed by the 
occupied enzyme entity, are blocked. The same results were obtained by inhibition of the 
amphetamine metabolism by the compound DPEA (10).
It is postulated by Bro d ie  (5) and U d en fr ien d  (13) that the cytochrome P-450 
hydroxylates the aromatic nucleus by the epoxide mechanism. Such a mechanism cannot 
be involved for the hydroxylation of the cycloalkyl ring.
What are the requirements for an enzymatic hydroxylation of cycloalkyl rings ? Is the 
activation energy of the rupture of the C-H bond the dominating factor or are there also 
any steric requirements? Is it possible to replace the cyclohexyl ring by a cyclopentyl 
ring without alteration of metabolic pathways. This should be possible if only the 
activation energy mentioned is determinant for the hydroxylation.
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The compound N-methylcyclopentylisopropylamine, cyclopentamine, is demethylated 
and excreted into the urine like methylamphetamine (Fig. 3). In man no ring hydroxylation 
could be observed. The cyclopentyl ring behaves like a phenyl ring, both ring systems 
appeared to have strong influence at the metabolic routes. The cyclopentyl ring is a planar 
ring system, chemically stable and without ring tension. It must be concluded that the 
hydroxylating enzyme can easily attack molecules with a certain flexibility in the C-H 
bond that can be attacked. This is the case with aliphatic carbon chains and alicyclic rir 
systems. A cyclopentyl ring is planar and rigid and the same holds for the phenyl ring.
urine ml/min -------------------------------------------------------------------------------------------- cumulatïve renal
Fig. 3. Renal excretion rate, cumulative renal excretion, urinary pH  and average urine production 
of cyclopentamine. The compound is excreted like methylamphetamine. Cyclopentamine: 
Ti/a =  7 hr, 70 % totally excreted unchanged, 5 % a-C-oxidation. Methylamphetamine: T 1/* =  
7 hr, 70 % excreted and 10 % a-C-oxidation. Even the relationship dose mg HC1 =  jug/min
max. excretion rate exists.
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D. N-cycloalkyl substituted amphetamines
With amphetamines the main metabolic pathways in man is the a-C-oxidation and 
with the saturated amphetamines a-C-oxidation competes with ring hydroxylation. Also 
the ‘flexibility’ of the ring is demonstrated. In N-cycloalkyl substituted amphetamines, 
all those competitive pathways are possible. In order to get information about relative 
<*ate constants of a-C-oxidation and alicyclic ring hydroxylation, the following compounds 
/ere investigated: N-cyclopentyl-, N-cyclohexyl-, and N-cycloheptylamphetamine (S+)- 
In this series the tertiary C-H bond of the cycloalkyl group has the same outstanding 
position as the corresponding tertiary C-H in the amphetamine moiety. The rate of 
formation of the metabolite amphetamine gives an indication about the sterical hindrance 
of the bulky ring system wheri the compound is attacked by the cytochrome P-450 for 
a-C-oxidation. In Table 6 compounds are compared with 2 tertiary C-H bonds available 
for a a-C-oxidation by the cytochrome.
T a ble  6
Metabolism of N-cycloalkyl substituted amphetamines. Comparison of the availability of the 
tertiary C-H- bond of the substituent for attack by the cytochrome P-450
Compound % dose excreted unchanged
% dose excreted 
as amphetamine
% dose excreted 
as ring hydroxyl- 
ated metabolite of 
N-cycloalkylamph.
(+ )  isopropylamphetamine 10 40 0
(+ )  N-cyclopentylamphetamine 3 30 0
( + )  N-cyclohexylamphetamine 1 5 18
^+) N-cycloheptylamphetamine 0 5 0
From the table it can be derived that all possible metabolic pathways do occur.
Cyclopentylamphetamme. The amount amphetamine formed and excreted in the urine 
indicated that the tertiary C-H of the cyclopentyl group can be attacked very easily by the 
cytochrome P-450. It is almost the same situation as observed with isopropylamphet- 
amine. The ring system exhibits no or very slight sterical hindrance in the interaction 
with the enzyme. The tertiary C-H binding can be attacked by the cytochrome when this 
group is adjacent to the nitrogen atom. However, in N-methylcyclopentylisopropyl- 
amine, this particular C-H group is not attacked at all (see Fig. 3). This means that the 
a- C-oxidation only occurs in the aliphatic side chain and that the nitrogen atom must 
be a ‘target* atom for the enzyme. Therefore it is also less probable that a-C-oxidation is 
responsible for hydroxylation of alicyclic ring systems.
Cyclohexylamphetamine: The low amount of amphetamine formed as metabolite from 
N-cyclohexylamphetamine indicates that the C-H bond is still accessible for attack by the 
cytochrome, but also that other metabolic pathways reduce the significance of this con- 
tribution to the total elimination. With N-cyclohexylamphetamine3 the main metabolite 
excreted in the urine is N-cyclohexanolamphetamine. The total amount was about 18%, 
and the OH group was distributed over the ring as follows: 0.8% C2,2.2% C3 and 15% 
C4. The situation is the same as observed with the saturated amphetamines. Again, 
a-C-oxidation and alicyclic ring hydroxylation are the competitive metabolic pathways.
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Cycloheptylamphetamine: As compared to the N-cyclohexylamphetamine, the seize 
of the ring has no influence at the rate of formation of amphetamine. It was not possible 
to detect alicyclic ring hydroxylated metabolites. The metabolic routes of this compound 
are not clear.
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